Inhibitor interaction in the suppression of ribosomal RNA synthesis in Ehrlich ascites carcinoma cells
Akhlynina, T.V.; Buzhurina, I.M.; Panov, M.A.; Rozovskaia, I.A.; Chernaia, I.G.
Tsitologiia 26(11): 1313-1318
1984
ISSN/ISBN: 0041-3771 PMID: 6523576 Document Number: 229431
Kinetic analysis of inhibitory action of papaverine, 2,4-dinitrophenol (DNP) and actinomycin D on RNA synthesis in the intact Ehrlich ascites carcinoma cells has shown that the action of these agents is mediated by their effect on the same step of rRNA synthesis.
Document emailed within 1 workday
Related Documents
Akhlynina, T.V.; Buzhurina, I.M.; Panov, M.A.; Rozovskaia, I.A.; Chernaia, N.G. 1985: Dependence of the nature of the action of metabolic inhibitors on ribosomal RNA synthesis in Ehrlich ascites carcinoma cells on cell integrity Tsitologiia 27(3): 348-352Akhlynina, T.V.; Buzhurina, I.M.; Panov, M.A.; Rozovskaia, I.A. 1979: Effect of cycloheximide, 2,4-dinitrophenol and papaverine on ribosomal RNA synthesis in Ehrlich ascitic carcinoma cells Tsitologiia 21(1): 84-89
Bielka, H.; Grosse, R.; Böhmer, F.; Junghahn, I.; Binas, B. 1986: Inhibition of proliferation of Ehrlich ascites carcinoma cells is functionally correlated with reduced activity of the cytosol to stimulate protein synthesis Biomedica Biochimica Acta 45(4): 441-445
Schulze, W.; Horn, G. 1970: Correlations between chemical structure and biological activity of azomethines with nitrogen-mustard-groups on Ehrlich ascites tumor in albino mice. 3. Activation of N-mustard-azomethines by cells of Ehrlich ascites carcinoma Arzneimittel-Forschung 20(3): 329-335
Dobaczewska, H. 1982: In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent leukocytes Neoplasma 29(3): 323-325
Ghosh, S. 1975: Nucleic acids and protein synthesis in adenosine treated Ehrlich mouse ascites tumour cells Indian Journal of Experimental Biology 13(3): 290-292
Probst, H.; Schiffer, H.; Gekeler, V.; Kienzle-Pfeilsticker, H.; Stropp, U.; Stötzer, K.E.; Frenzel-Stötzer, I. 1988: Oxygen dependent regulation of DNA synthesis and growth of Ehrlich ascites tumor cells in vitro and in vivo Cancer Research 48(8): 2053-2060
Mukherjee, K.; Ghosh, S.; Ray, M.; Ray, S. 2002: Purification and characterization of 3-phosphoglycerate kinase from Ehrlich ascites carcinoma cells Indian Journal of Biochemistry and Biophysics 39(5): 332-341
Il'ina, K.P.; Merkle, K. 1973: Population size and calculation of the generation time of Ehrlich ascites carcinoma cells Voprosy Onkologii 19(1): 70-74
Fan, Y.J.; Zhou, J.; Li, M. 1981: Effect of nitidine chloride on the life cycle of Ehrlich ascites carcinoma cells in mice Zhongguo Yao Li Xue Bao 2(1): 46-49
Sturdík, E.; Drobnica, L. 1983: The cytotoxic action of granaticin, a sulfhydryl-reactive antibiotic, on Ehrlich ascites carcinoma cells Neoplasma 30(1): 3-6
Matsak, N.I.; Romanov, I.A.; Antokhin, A.I. 1983: Comparative study of the action of an inhibitor and a stimulator present in Ehrlich ascites tumor cells on cell proliferation in the tumor Biulleten' Eksperimental'noi Biologii i Meditsiny 96(12): 74-76
Podhajcer, O.L.; Friedlander, M.; Graziani, Y. 1980: Effect of liposome-encapsulated quercetin on DNA synthesis, lactate production, and cyclic adenosine 3':5'-monophosphate level in Ehrlich ascites tumor cells Cancer Research 40(4): 1344-1350
Evtodienko, I.V.; Teplova, V.V.; Sidash, S.S.; Voĭtchak, L. 1995: Redistribution of Ca2+ ions in Ehrlich ascites carcinoma cells under the action of deoxyglucose and inhibitors of the intracellular Ca2+- transporting system Biokhimiia 60(8): 1336-1343
Higuchi, Y.; Shoin, S. 1980: Cytotoxic and cytolytic action of the subcellular fraction (60-F) of live hemolytic streptococci against Ehrlich ascites carcinoma cells Gan 71(2): 220-225
Zardi, L.; Cecconi, C.; Barbieri, O.; Carnemolla, B.; Picca, M.; Santi, L. 1979: Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells Cancer Research 39(9): 3774-3779
Morio, T.; Nonoyama, S.; Yata, J. 1989: Suppression of in vitro immunoglobulin synthesis by CD16(Leu11a)+ CD56 (NKH1,Leu19)+non-T lineage NK cells; lack of suppression of cells from immunodeficient patients Clinical and Experimental Immunology 78(2): 159-165
Gonzenbach, P. 1970: Growth and spread of Ehrlich ascites carcinoma of the mouse in the chick embryo Pathologia et Microbiologia 36(4): 200-214
Sur, P.; Bag, S.P.; Sur, B.; Khanam, J.A. 1997: Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice Neoplasma 44(3): 197-201
Yamazaki, H.; Nitta, K.; Umezawa, H. 1973: Immunosuppression induced with cell-free fluid of Ehrlich carcinoma ascites and its fractions Gan 64(1): 83-92